|
|
S&P 500
7,609.78
+9.82 (0.13%)
|
|
Dow Jones
51,307.79
+228.91 (0.45%)
|
|
NASDAQ
27,093.90
+7.09 (0.03%)
|
|
Market close: June 2, 2026
|
|
|
Stock Market Today
|
Dow, S&P 500, Nasdaq futures mixed as AI fervor meets
US-Iran uncertainty
US stock futures traded mixed early Wednesday as
investors balanced strong momentum from AI-related
earnings against ongoing uncertainty surrounding US-Iran
negotiations.
Dow Jones Industrial Average futures fell 0.3%, while
S&P 500 futures slipped about 0.1%.
Nasdaq 100 futures edged 0.2% higher, supported by
continued strength in technology stocks.
Recent earnings reports from companies such as Dell and
Hewlett Packard Enterprise reinforced investor
confidence that AI spending is translating into
meaningful business growth, helping push major indexes
to fresh record highs on Tuesday.
At the same time, markets remain cautious as diplomatic
talks between the US and Iran continue without a clear
resolution, leaving geopolitical risks in focus.
Yahoo
Finance
reports.
|
|
|
Image source: Lummi
|
|
|
EdgeUp
|
🔭 Astrotech's 1,100% rocket ride under fire as short
seller calls it "fundamentally uninvestable"
Astrotech Corporation's rally came under pressure after
short seller Fugazi Research released a report
questioning the company's strategy, revenue base, and
corporate governance structure.
The report described the stock as "fundamentally
uninvestable" and warned of a potential "99%
correction."
Following the report, Astrotech shares fell more than
15% in Wednesday premarket trading as investors reacted
to the allegations and reassessed the company's recent
surge.
Benzinga
reports.
|
|
🧬 Lilly gains license for Ascidian's gene-editing
tech to develop kidney disease drugs
Ascidian Therapeutics announced a licensing agreement
with Eli Lilly worth up to $1.9 billion to develop new
treatments for rare inherited kidney diseases.
Under the deal, Lilly receives exclusive rights to use
Ascidian's RNA exon-editing technology for certain
undisclosed kidney disease targets.
The technology is designed to repair faulty genes at the
RNA level without permanently modifying a patient's DNA,
offering a potentially safer and more flexible approach
to genetic medicine.
The agreement highlights continued investment by major
pharmaceutical companies in next-generation gene-editing
technologies as they seek new treatments for rare and
difficult-to-treat diseases. Yahoo
Finance
reports.
|
|
⚛️ INFQ back on radar after UK quantum push; shares
jump
Infleqtion shares moved sharply higher late Tuesday as
renewed investor interest in the quantum computing
sector lifted the stock.
The rally was supported by a recent U.K. quantum
technology initiative and broader strength across
publicly traded quantum computing companies.
As a relatively new public company, Infleqtion remains a
developing story for investors, who are evaluating the
value of its government quantum contracts, manufacturing
ambitions, and path toward commercialization.
Like many quantum technology firms, Infleqtion faces
questions around timing and profitability, as the
industry is still in the early stages of commercial
adoption.
The stock's move reflects growing investor interest in
companies positioned to benefit from long-term advances
in quantum computing and related technologies. TechStock²
reports.
|
|
🔬 Rigetti moves up, but new filings keep quantum
trades on edge
Rigetti Computing shares gained 4.9% on Tuesday to close
at $26.88, giving the quantum computing company a market
capitalization of approximately $9.0 billion.
The stock's latest move came as investors reviewed new
insider filings while broader enthusiasm for quantum
computing stocks was supported by recent policy
developments.
Rigetti remains one of the few publicly traded pure-play
quantum computing companies, making it a popular but
highly volatile name among investors seeking exposure to
the sector.
Quantum computing is still in its early stages, with
companies racing to develop systems that use qubits to
solve certain problems that are difficult for
traditional computers.
The combination of regulatory developments, insider
activity, and growing interest in next-generation
computing technologies continues to keep quantum stocks
in focus.
TechStock²
reports.
|
|
🔗 Corning shares move after AI news
Corning shares surged Tuesday, reversing Monday's
decline as investors rotated into companies tied to the
optical infrastructure supporting AI data centers.
The stock was last trading at $200.40, up $23.66 on the
session, with more than 18 million shares changing
hands.
Investor interest is increasingly expanding beyond
semiconductor makers to include the broader ecosystem
that powers AI infrastructure.
Companies involved in optical fiber, connectivity
hardware, networking equipment, glass technologies, and
high-speed data transmission are attracting attention as
demand grows for the systems that connect thousands of
GPUs inside large AI data centers.
The move highlights a broader market trend in which
AI-related investment is spreading across the entire
data center supply chain, not just chip manufacturers.
TechStock²
reports
|
|
🎮 GameStop stock jumps after Q1 double beat, $2
billion buyback authorization
GameStop shares moved higher Wednesday after the company
reported first-quarter results that exceeded Wall Street
expectations on both revenue and earnings, while also
announcing a new $2 billion share repurchase program.
The company reported revenue of $835.3 million, topping
analyst estimates of $766.64 million.
Earnings came in at 30 cents per share, well ahead of
the consensus forecast of 16 cents per share.
GameStop also reported first-quarter net income of
$389.6 million, the highest quarterly net income in the
company's history.
Operating income reached $143.3 million, marking the
strongest first-quarter operating performance ever
recorded by the company.
The newly approved $2 billion buyback authorization
further boosted investor sentiment, signalling
management's confidence in the company's financial
position.
Benzinga
reports.
|
|
🧬 TransCode's RNA therapeutic achieves 64% stable
disease rate in colorectal cancer Phase 1 study
TransCode Therapeutics announced Wednesday that it has
successfully completed the Phase 1a dose-escalation
clinical trial of its lead cancer therapeutic candidate,
TTX-MC138.
It met its primary safety objectives and demonstrated
durable disease stabilization in patients with advanced
metastatic cancer.
Benzinga
reports.
|
|
|
The $25,000 day trading minimum ends
tomorrow. TradeZero is ready for it.
|
|
Tomorrow, June 4, TradeZero America goes PDT-free. The
$25,000 minimum equity requirement for unrestricted day
trading will be gone — at market open, 9:30 AM ET.
And our summer promotion kicks in automatically:
- 50% off options contract fees — $0.21 per
contract (down from $0.42)
- 15% off every eligible locate fee
Automatically applied from June 4 through September
4, 2026. No sign-up code needed. Dormant accounts
that reactivate during the period also qualify. T&Cs
apply.
Active trading and day trading involve substantial
risk and are not suitable for all investors.
Investors may lose more than their initial
investment.
|
See the
full summer promotion
|
|
|
Join Us Live Today
|
|
A lot has happened in the lead-up to June 4 — and there
are still questions traders want answered.
Join us live
on Wednesday, June 3 at 12:30 PM ET for a walkthrough of
our latest releases — and a live PDT Rule Q&A.
We'll cover:
- Enhanced news functionality
- New market microstructure window
- Introducing Quick locates (ZeroPro only) – in
Level 2 window
- Integrated margin requirement visibility
directly inside Level 2
- Remaining trader questions ahead of June 4
Whether you joined our previous session or are just
getting up to speed, this is your opportunity to see the
latest platform enhancements in action and hear directly
from the team before the June 4 changes take effect.
|
Save Your
Seat
|
|
|
Trading Strategies
|
Understanding the Island Reversal: A Two-Gap Pattern
That May Signal Shifting Sentiment
In my latest TradeZero piece, I break down one of the
more visually striking patterns in technical analysis:
the Island Reversal, and how traders use it to identify
potential bearish reversal setups.
The pattern forms when price gaps sharply upward,
consolidates briefly, and then gaps back down in the
opposite direction, leaving an isolated "island" of
price action separated on both sides by empty space on
the chart. That two-gap structure is what makes the
pattern distinctive, and in my view it reflects a rapid
shift in market psychology: early enthusiasm fades,
conviction weakens, and buyers who entered late may find
themselves trapped as selling pressure takes over.
I walk through how to identify a valid setup, why volume
behavior at each stage matters, how traders typically
approach entries and stop placement, and the most common
pitfalls, including misidentifying the pattern, entering
before confirmation, and overlooking broader market
conditions that could override the signal.
The pattern is considered most meaningful after a strong
uptrend, particularly in news-driven, overextended, or
small cap stocks. Used as part of a broader technical
analysis framework, it can provide short sellers with a
structured way to assess potential reversal setups. This
content is for educational purposes only and past
performance is not indicative of future results.
|
Read the full post
|
|
|
Top 5 Movers in Early Pre-Market
|
(All pricing and percent gains are based on Early
Pre-Market from 4:00 AM to 7:00 AM ET)
Stock Analysis reports.
|
|
Total gain: +247.09%
|
|
2) MSAI: MultiSensor AI
Holdings, Inc.
Total gain: +65.14%
|
|
3) SDOT: Sadot Group Inc.
Total gain: +60.06%
|
|
4) LASE: Laser Photonics
Corporation
Total gain: +49.59%
|
|
5) NCT: Intercont (Cayman)
Limited
Total gain: +22.41%
|
|
|
Today’s Economic Dates
|
|
Time (ET)
|
Report
|
Period
|
|
8:15 AM
|
ADP employment
|
May
|
|
9:00 AM
|
Federal Reserve governor Michael Barr speech
|
N/A
|
|
9:45 AM
|
S&P final U.S. services PMI
|
May
|
|
View
more
|
|
|
Yesterday's Biggest Movers
|
|
The closing price of the top three market percent
gainers trading near or above $3 on
June 2.
|
All pricing and percent gains are based on regular
market trading hours from 9:30 AM to
4:00 PM ET
Stock Analysis reports.
|
1) DXST: Decent
Holding Inc.
Total gain: +209.38%
The stock appeared to be moving on no notable news.
|
|
2) BJDX:
Bluejay Diagnostics, Inc.
Total gain: +100.00%
The company announced that it has entered into
definitive agreements for the purchase
and sale of an aggregate of 3,655,917 shares of
common stock (or pre-funded
warrant in lieu thereof), series G warrants to
purchase up to 3,655,917 shares
of common stock and short-term series H warrants to
purchase up to
3,655,917 shares of common stock at a purchase price
of $2.325 per share of
common stock (or per pre-funded warrant in lieu
thereof) and accompanying
warrants in a private placement priced at-the-market
under Nasdaq rules.
Globe
Newswire
reports.
|
|
3) VIDA: VIDA
Global Inc.
Total gain: +53.46%
The stock appeared to be moving on no notable news.
|
|
|
Refer a Friend & Earn Together
|
|
Did you know that it pays to invite your friends to
TradeZero?
|
|
When they fund a new account with us, you’ll both
receive $100 USD. T&Cs apply.
|
|
Learn
more
|
|
|
Today’s Notable Earnings
|
Estimate and Actual numbers represent Earnings Per Share in US
Dollars
|
|
|
FIVE
Five Below
Q1 2026
|
After Market Close
Estimate: 1.680
Actual: N/A
|
|
|
|
RENT
Rent the Runway
Q1 2026
|
Before Market Open
Estimate: N/A
Actual: N/A
|
|
|
|
CHPT
ChargePoint Hldgs
Q1 2027
|
After Market Close
Estimate: -1.180
Actual: N/A
|
|
View more
|
|
Enjoying the DailyEdge?
|
|
Recommend our 5-minute daily digest to a friend by
sharing
this
link.
|
|
|
Parting Thoughts
|
|
“The greatest investing error comes not from factors
that are informational or analytical, but from those
that are psychological.”
|
|
– Howard Marks
|
|
Sourced in: The Most Important
Thing — OakTreeCapital.
|
|
|
|
TradeZero America, Inc., member of FINRA and
SIPC. Investing involves risk, including the
possible loss of principal.
The information in this newsletter
summarizes the latest market activity and
related news and are provided for
educational purposes only. Any trading
symbols displayed are for illustrative
purposes only and do not constitute a
recommendation by TradeZero to buy, sell, or
hold any investment. This material is not
intended to provide investment advice or to
take into account any individual’s financial
condition, investment objectives, or
requirements.
Stocks experiencing significant price
volatility may involve substantial risk.
Past performance is no guarantee of future
results.
Options trading is not suitable for all
investors as it can involve risk that may
expose investors to significant losses.
Please read the Characteristics and Risks of
Standardized Options, also known as the
Options Disclosure Document (ODD) at OCC.
Any trading strategies discussed are for
educational purposes only and should not be
construed as investment advice or a
recommendation.
Certain information herein has been obtained
from third-party sources believed to be
reliable; however, its accuracy or
completeness cannot be guaranteed. The views
and opinions expressed are those of the
author and do not necessarily reflect the
views or opinions of TradeZero, its
affiliates, or employees.
If you have any specific questions about
TradeZero's brokerage services, please reach
out to the TradeZero Broker Dealer servicing
your jurisdiction.
Copyright © TradeZero 2026. All rights
reserved.
|
|
|
|
